Der Hautarzt

, Volume 56, Issue 11, pp 1084–1100

Syphilis

Leitlinie der DSTDG zur Diagnostik und Therapie
  • H. Schöfer
  • N. H. Brockmeyer
  • H.-J. Hagedorn
  • O. Hamouda
  • W. Handrick
  • W. Krause
  • U. Marcus
  • D. Münstermann
  • K. U. Petry
  • H. Prange
  • A. Potthoff
  • G. Gross
Mitteilungen der Deutschen STD-Gesellschaft (DSTDG)

Literatur

  1. 1.
    Ali L, Roos KL (2002) Antibacterial therapy of neurosyphilis, lack of impact of new therapies. CNS Drugs 16:799–802PubMedGoogle Scholar
  2. 2.
    Azimi PH et al. (1994) Concentrations of procaine and aqueous penicillin in the cerebrospinal fluid of infants treated for congenital syphilis. J Pediatr 124:649–653PubMedGoogle Scholar
  3. 3.
    Backhouse JL, Nesteroff SI (2001) Treponema pallidum western blot: comparison with the FTA-ABS test as a confirmatory test for syphilis. Diagn Microbiol Inf Dis 39:9–14CrossRefGoogle Scholar
  4. 4.
    Beck-Sague C, Alexander ER (1987) Failure of benzathine penicillin G treatment in early congenital syphilis. Pediatr Infect Dis J 6:1061–1064PubMedGoogle Scholar
  5. 5.
    Beeram MR, Chopade N, Dawood Y, Siriboe St, Abedin M (1996) Lumbar puncture in the evaluation of possible asymptomatic congenital syphilis in neonates. J Pediatr 128:125–129PubMedGoogle Scholar
  6. 6.
    Berry CD, Hooton TM, Collier A, Lukehart S (1987) Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 316:1587–1589PubMedGoogle Scholar
  7. 7.
    Bracero L, Wormser GP, Bottone EJ (1979) Serologic tests for syphilis: a guide to interpretation in various states of disaese. Mt Sinai J Med 46:289–292PubMedGoogle Scholar
  8. 8.
    Brandon WR, Boulos LM, Morse A (1993) Determining the prevalence of neurosyphilis in a cohort co-infected with HIV. Int J STD AIDS 4:99–101PubMedGoogle Scholar
  9. 9.
    Brockmeyer NH (2001) Syphilis. In: Petzoldt D, Gross G (Hrsg) Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. Springer, Berlin Heidelberg New York, S 101–111Google Scholar
  10. 10.
    Brown ST, Zaidi A, Larsen SA, Reynolds GH (1985) Serological response to syphilis treatment. A new analysis of old data. JAMA 253:1296–1299CrossRefPubMedGoogle Scholar
  11. 11.
    Bundesgesundheitsamt (1979) Richtlinien 1979 für die Serodiagnose der Syphilis. Bundesgesundheitsbl 22:398–400Google Scholar
  12. 12.
    Burke JM, Schaberg DR (1985) Neurosyphilis in the antibiotic era. Neurology 35:1368–1371PubMedGoogle Scholar
  13. 13.
    Carey J (2003) Congenital syphilis in the 21st century. Curr Womens Health Rep 3:299–302PubMedGoogle Scholar
  14. 14.
    Centers for Disease Control and Prevention (2004) Azithromycin treatment failures in syphilis infections- San Francisco, California, 2002–2003. MMWR Morb Mortal Wkly Rep 53:197–198PubMedGoogle Scholar
  15. 15.
    Centers for Disease Control and Prevention (1998) 1998 Guidelines for treatment of sexually transmitted disease. MMWR Morb Mortal Wkly Rep 47:1–111PubMedGoogle Scholar
  16. 16.
    Centers for Disease Control and prevention (2002) Sexually transmitted disease treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 51 (RR-6): 1–78Google Scholar
  17. 17.
    Chisholm CA, Katz VL, McDonald TL, Bowes WA jr (1997) Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol 14:553–554PubMedGoogle Scholar
  18. 18.
    Clark EG, Danbolt N (1955) The Oslo study of the natural history of untreated syphilis. An epidemiologic investigation based on a restuda of the Boeck-Brunsgaard material. J Chronic Dis 2:311–344CrossRefPubMedGoogle Scholar
  19. 19.
    Clinical Effectiveness Group; Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases (1999) National guideline for the management of late syphilis. Sex Transm Infec 75 (Suppl):S34-S37Google Scholar
  20. 20.
    Czelusta A, Yen Moore A, Straaten M van der, Carrasco D, Tyring SK (2000) An overview of sexually transmitted diseases Part 3. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 3:409–432CrossRefGoogle Scholar
  21. 21.
    Dilley JW, Klausner JD, Mc Farland W et al. (2004) Trends in primary and secondary syphilis and HIV infections in men who have sex with men. San Francisco and Los Angeles, California 1998–2002Google Scholar
  22. 22.
    Dorfman DH, Glaser JH (1990) Congenital syphilis presenting in infants after the newborn period. N Engl J Med 323:1299–1302PubMedGoogle Scholar
  23. 23.
    Dowell ME, Ross PG, Musher DM et al. (1992) Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 93:481–488CrossRefPubMedGoogle Scholar
  24. 24.
    Ducas J, Robson HG (1981) Cerebrospinal fluid penicillin levels during therapy for latent syphilis. JAMA 246:2583–2584CrossRefPubMedGoogle Scholar
  25. 25.
    Fonseca E, Garcia-Silva J, del Pozo J, Yebra MT, Cuevas J, Contrer F (1999) Syphilis in an HIV-positive patient misdiagnosed as leprosy. J Cutan Pathol 1:51–54Google Scholar
  26. 26.
    Goeman J, Kivuvu M, Nzila N et al. (1995) Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 71:275–279PubMedGoogle Scholar
  27. 27.
    Goh BT, Smith GW, Samarasinghe L et al. (1984) Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid. Br J Vener Dis 60:371–373PubMedGoogle Scholar
  28. 28.
    Goldenberg R, Thompson C (2003) The infectious origins of stillbirth. Am J Obstet Gynecol 189:861–873CrossRefPubMedGoogle Scholar
  29. 29.
    Gordon SM, Eaton ME, George R, Larsen S, Lukehart SA, Kuypers J, Marra CM, Thompson S (1994) The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immuno-deficiency virus infection. N Engl J Med 331:1469–1473CrossRefPubMedGoogle Scholar
  30. 30.
    Gruber F, Kastelan M, Cabrijan L, Simonic E, Brajac I (2000). Treatment of early syphilis with azithromycin. J Chemother 12:240–243PubMedGoogle Scholar
  31. 31.
    Hagedorn HJ, Kraminer-Hagedorn A, Wiegel U (1983) Prophylaxe und Diagnostik der Syphilis connata aus immunologischer Sicht. Dtsch Med Wochenschr 108:142–145PubMedGoogle Scholar
  32. 32.
    Hahn RD, Webster B, Weickhardt G et al. (1958) The results of treatment of 1086 general paralytics the majority of whom were followed up for more than 5 years. J Chron Dis 7:209–227CrossRefPubMedGoogle Scholar
  33. 33.
    Hall CS, Klausner JD, Bolan GA (2004) Managing syphilis in the HIV-infected patient. Curr Infect Dis Rep 6:72–81PubMedGoogle Scholar
  34. 34.
    Hamouda O, Marcus U (2005) Syphilis auf dem Vormarsch. Hautarzt 56:124–132CrossRefPubMedGoogle Scholar
  35. 35.
    Handrick W, Blatz R, Schroten H (2003) Lues connata. In: Deutsche Gesellschaft für pädiatrische Infektiologie (Hrsg) Handbuch Infektionen bei Kindern und Jugendlichen. 4 Aufl. Futuramed, München, S 470–476Google Scholar
  36. 36.
    Handrick W, Seemann U, Blatz R, Nietzschmann M (2003) Lues connata. Eine retrospektive Analyse. Pädiat prax 63:277–284Google Scholar
  37. 37.
    Hook EW, Marra CM (1992) Acquired syphilis in adults. N Engl J Med 326:1060–1069PubMedGoogle Scholar
  38. 38.
    Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K (2002) A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 29:486–490PubMedGoogle Scholar
  39. 39.
    Hutchinson CM, Hook EW (1990) Syphilis in adults. Med Clin Norh Am 74:1389–1416Google Scholar
  40. 40.
    Idsoe O, Guthe T, Willcox RR (1972) Penicillin in the treatment of syphilis: the experience of three decades. Bull World Health Org 47 (Suppl 1):1–68Google Scholar
  41. 41.
    Kent CK, Wolf W, Nieri G, Wong W, Klausner JD (2003) Internet use and early syphilis infection among men who have sex with men: San Francisco, California, 1999–2003 MMWR Morb Mortal Wkly Rep 52:1229–1232Google Scholar
  42. 42.
    Kingston MA, Higgins SP (2004) Audit of the management of early syphilis at North Manchester General Hospital Int J STD AIDS 15(5):352–354Google Scholar
  43. 43.
    Kingston MA, Higgins SP (2004) Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals. Sex Transm Infec 80:152–153CrossRefGoogle Scholar
  44. 44.
    Körber A, Dissemond J, Lehnen M, Franckson T, Grabbe S, Esser S (2004) Syphilis bei HIV-Koinfektion JDDG 2:833–840Google Scholar
  45. 45.
    Koppermann M, Körber A, Grabbe S, Esser S (2004) Diagnosis of neurosyphilis by cerebrospinal fluid in HIV-positive patients with primary or secondary infectious syphilis and CSF-repuncture after 12 months for therapy control after intravenous penicillin G treatment. The XV International AIDS Conference, Bangkok 2004, Abstract no. MoPeB3283Google Scholar
  46. 46.
    Korting HC, Walther D, Riethmüller U et al. (1986) Comparative in vivo susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy 32:352–355PubMedGoogle Scholar
  47. 47.
    Larsen SA, Steiner BM, Rudolph AH (1995) Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 8:1–21PubMedGoogle Scholar
  48. 48.
    Luger A, Schmidt BL, Steyrer K, Schonwald E (1981) Diagnosis of neurosyphilis: examination of cerebrospinal fluid. Br J Vener Dis 57:232–237PubMedGoogle Scholar
  49. 49.
    Lukehart SA, Godornes C, Molini BJ et al. (2004) Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 351:154–158CrossRefPubMedGoogle Scholar
  50. 50.
    Lukehart SA, Hook EW, Baker-Zander SA et al. (1988) Invasion of the central nervous system by Treponema pallidum: implications for diagnosis und treatment. Ann Intern Med 109:855–862PubMedGoogle Scholar
  51. 51.
    Malessa R, Agelink MW, Hengge U, Mertins L, Gastpar M, Brockmeyer NH (1996) Oligosymptomatic neurosyphilis with false negative CSF-VDRL in HIV-infected individuals. Eur J Med Res 1:299–302PubMedGoogle Scholar
  52. 52.
    Mandelbrot L, Marcollet A (2004) Syphilis au cours de la grossesse. Rev Prat 54:392–395PubMedGoogle Scholar
  53. 53.
    Marcus U, Kiehl W, Hamouda O (2003) Zur aktuellen Entwicklung der Syphilis in Deutschland. Hautarzt 54:1125–1130CrossRefPubMedGoogle Scholar
  54. 54.
    Marra CM, Boutin P, McArthur JC et al. (2000) A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 30:540–544CrossRefPubMedGoogle Scholar
  55. 55.
    Marra CM, Maxwell CL, Smith SL et al. (2004) Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 189:369–376CrossRefPubMedGoogle Scholar
  56. 56.
    McBroom RL, Styles AR, Chiu MJ, Clegg C, Cockerell CJ, Radolf J (1999) Secondary syphilis in persons infected with and not infected with HIV-1: a comparative immunhistologic study. Am J Dermatopathol 5:432–441CrossRefGoogle Scholar
  57. 57.
    Michelow IC, Wendel GD, Norgard MV, Zeray F, Leos K, Alsaadi R, Sanchez PJ (2002) Central nervous system infection in congenital syphilis. N Engl J Med 346:1792–1798CrossRefPubMedGoogle Scholar
  58. 58.
    MIQ 16 (2001) Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik: Syphilis (erarbeitet von H.-J. Hagedorn). Urban & Fischer, München Jena, S 1–40Google Scholar
  59. 59.
    Müller F, Hagedorn HJ (1998) Syphilis. In: Thomas L (Hrsg) Labor und Diagnose. TH-Books, Frankfurt am Main, S 1232–1241Google Scholar
  60. 60.
    Musher DM, Hamill RJ, Baughn RE (1990) Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Int Med 113:872–881PubMedGoogle Scholar
  61. 61.
    Myint M, Baschiri H, Harrington RD, Marra CM (2004) Relapse of secondary syphilis after benzathine penicillin G: molecular analysis. Sex Transm Dis 31:195–199Google Scholar
  62. 62.
    Nau R, Prange HW, Muth P et al. (1993) Passage of cefotaxime and ceftriaxone into the cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 27:1518–1524Google Scholar
  63. 63.
    Norgard MV, Miller JN (1981) Plasmid DNA in Treponema pallidum: potential for antibiotic resistance by syphilis bacteria. Science 213:535Google Scholar
  64. 64.
    O’Mahony C, Rodgers CA, Mendelsohn SS, Sissons G, McKay A, Devine J, Keeping IM (1997) Rapidly progressive syphilis in early HIV infection. Int J STD AIDS 8:275–277CrossRefPubMedGoogle Scholar
  65. 65.
    Pao D, Goh BT, Bingham JS (2002) Management issues in syphilis. Drugs 62:1447–1461PubMedGoogle Scholar
  66. 66.
    Parkes R, Renton A, Meheus A, Laukamm-Josten U (2004) Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 15:73–88CrossRefPubMedGoogle Scholar
  67. 67.
    Paryani SG, Vaughn AJ, Crosby M, Lawrence S (1994) Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 125:471–475PubMedGoogle Scholar
  68. 68.
    Pehamberger H (1981) Single dose treatment of primary syphilis with Benzathine penicillin. Wien Med Wochenschr 131:213–215PubMedGoogle Scholar
  69. 69.
    Potthoff A, Brockmeyer NH (2005) Syphilis und HIV-Infektion Besonderheiten der Diagnose, Klinik und Therapie. Hautarzt 56:133–140CrossRefPubMedGoogle Scholar
  70. 70.
    Prange H (1987) Neurosyphilis. edition medizin. VCH-Verlag, WeinheimGoogle Scholar
  71. 71.
    Prange H, Ritter G (1981) Epidemiologie der Neurosyphilis. Nervenarzt 52:32–35PubMedGoogle Scholar
  72. 72.
    Prange H, Bobis-Seidenschwanz I (1994/95) Zur Evaluierung serologischer Aktivitätskriterien bei Neurosyphilis. Verh Dtsch Ges Neurol 8:789–791Google Scholar
  73. 73.
    Prange H (1995) Neurosyphilis. In: Prange H (Hrsg) Infektionskrankheiten des ZNS. Chapman & Hill, London, pp 237–250Google Scholar
  74. 74.
    Quinn TC, Bender B (1988) Sexually transmitted diseases. In: Harvey AM, Johns RJ, McKusick VA et al. (eds) The principles and practice of medicine. 22nd edn. Norwalk, CT Appleton & Lange, gg1–663Google Scholar
  75. 75.
    RKI (2002) Neurosyphilis—Fallbericht, Bedeutung, Diagnostik und Prävention. Epid Bull 5:35–36Google Scholar
  76. 76.
    RKI (2003) Praktische Empfehlungen zur Serodiagnostik der Syphilis. Epid Bull 25;191–192Google Scholar
  77. 77.
    RKI (2004). Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Berichtsmonat Dezember 2003. Epid Bull 10:85Google Scholar
  78. 78.
    RKI (2004) Syphilis in Deutschland 2003. Interpretation der Meldedaten nach dem IfSG. Epid Bull 40:339–343Google Scholar
  79. 79.
    RKI (2004) Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Berichtsmonat April 2004. 28:223Google Scholar
  80. 80.
    Rockwell DH, Yobs AR, Moore MB (1964) The Tuskegee study of untreated syphilis. Arch Intern Med 114:792–798PubMedGoogle Scholar
  81. 81.
    Rolfs RT, Joesoef RM, Hendershot EF et al. (1997) A randomised trial of enhanced therapy for early syphilis in patients with and without HIV infection. N Engl J Med 337:307–314CrossRefPubMedGoogle Scholar
  82. 82.
    Rompalo AM, Joesoef MR, O’Donnell JA et al. (2001) Clinical manifestations of early syphilis by HIV-status and gender: results of the syphilis and HIV study. Sex Transm Dis 28:158–165CrossRefPubMedGoogle Scholar
  83. 83.
    Rompalo AM, Lawlor J, Seaman P, Quinn TC, Zenilman JM, Hook EW (2001) Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 28:448–454PubMedGoogle Scholar
  84. 84.
    Schmid GP (1990) Approach to the patient with genital ulcer disease. Med Clin North Am 74:1559PubMedGoogle Scholar
  85. 85.
    Schmidt BL, Edjlalipour M, Luger A (2000) Comparative evaluation of nine different enzyme-linked immunosorbent assay for determination of antibodies against Treponema pallidum in patients with primary syphilis. J Clin Microbiol 38:1279–1282PubMedGoogle Scholar
  86. 86.
    Schöfer H, Imhof M, Thoma-Greber E et al. (1996) Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med 72:176PubMedGoogle Scholar
  87. 87.
    Schöfer H (2004) Syphilis. Klinische Aspekte der Treponema pallidum Infektion. Hautarzt 55:112–119CrossRefPubMedGoogle Scholar
  88. 88.
    Schöfer H (2005) Behandlung der Syphilis. Deutsche und internationale Leitlinien – ein Vergleich. Hautarzt 56:141–150CrossRefPubMedGoogle Scholar
  89. 89.
    Schrag S, Arnold K, Mohle-Boetani J et al. (2003) Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 102:753–760CrossRefPubMedGoogle Scholar
  90. 90.
    Sellati TJ, Wilkinson DA, Sheffield JS, Koup RA, Radolf JD, Norgard MV (2000) Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J Infect Dis 1:283–293CrossRefGoogle Scholar
  91. 91.
    Serragui S, Yahyaoui M, Hassar M, Chkili T, Bouhaddioui N, Soulaymani R (1999) A comparison study of two therapeutic protocols for neurosyphilis.Therapie 54:613–621PubMedGoogle Scholar
  92. 92.
    Singh AE, Romanowski B (1999) Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 12:187–209PubMedGoogle Scholar
  93. 93.
    Smith NH, Musher DM, Huang DB, Rodriguez PS, Dowell ME, Ace W, White AC (2000) Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicilline. Int J STD AIDS 15:328–332CrossRefGoogle Scholar
  94. 94.
    Smith G, Holmann RP (2004) The prozone phenomenon with syphilis and HIV co-infection. South Med J 97:327–328PubMedGoogle Scholar
  95. 95.
    Stapleton JT, Stamm LV, Bassford PJ (1985) Potential for development of antibiotic resistance in pathogenic treponemes. Rev Infect Dis 7 (Suppl 2) S314-S317Google Scholar
  96. 96.
    Todd G, Krause W (2003) Sexually transmitted diseases. In: Hansen RO, Schacher (eds) Pediatric dermatology, 3rd edn. Elsevier, New YorkGoogle Scholar
  97. 97.
    Vécsei AKW, Vécsei PV, Dangl-Erlach E, Gadner H (1999) Lues connata: späte Diagnose trotz Screenings. Wien Klin Wochenschr 111:410–413PubMedGoogle Scholar
  98. 98.
    Zenker PN, Rolfs RT (1990) Treatment of syphilis 1989. Rev Infect Dis 12 (Suppl 6): 591–609PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2005

Authors and Affiliations

  • H. Schöfer
    • 1
  • N. H. Brockmeyer
  • H.-J. Hagedorn
  • O. Hamouda
  • W. Handrick
  • W. Krause
  • U. Marcus
  • D. Münstermann
  • K. U. Petry
  • H. Prange
  • A. Potthoff
  • G. Gross
  1. 1.Zentrum der Dermatologie und VenerologieJohann Wolfgang Goethe-UniversitätFrankfurt am Main

Personalised recommendations